Author:
Mellstedt H.,Österborg A.,Björkholm M.,Björeman M.,Brenning G.,Gahrton G.,Grimfors G.,Gyllenhammar H.,Hast R.,Johansson B.,Juliusson G.,Järnmark M.,Killander A.,Kimby E.,Lerner R.,Merk K.,Paul C.,Simonsson B.,Smedmyr B.,Stalfelt A-M,Strander H.,Svedmyr E.,Udén A-M,Wadman B.,Ösby E.
Subject
Hematology,General Medicine
Reference16 articles.
1. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens;Alexanian;JAMA,1969
2. Chemotherapy of previously untreated multiple myeloma patients: An analysis of recent treatment results;Sporn;Semin Oncol,1986
3. Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III - A randomized study from MGCS;Österborg;Eur J Hematol,1989
4. Treatment of multiple myeloma with natural α-interferon;Mellstedt;Hemat Oncol,1988
5. Human leukocyte interferon and intermittent high dose melphalan/prednisone administration in the treatment of multiple myeloma: A randomized clinical trial from the Myeloma Group of Central Sweden (MGCS);Åhre;Cancer Treat Rep,1984
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献